After living with diabetes for over 50 years, and witnessing few changes in the treatment of the disease, Brent Hoadley has written Too Profitable to Cure.

Distressed that the cure is no closer now than when he was diagnosed, at the age of 14 -- Hoadley took it upon himself to find answers. He notes the current state of healthcare for those who suffer from chronic diseases, and contends that profit, not humanitarianism, is driving American healthcare. As an entrepreneur and an investor, he is aware, and appreciates the profit motive that drives capitalism. However, he feels the bottom line should not interfere with the pursuit of a cure. With pragmatic drive, he identifies culprits and urges activism as a countermeasure.

Diabetes is only one shining example of the pharmaceutical industry's criminal pursuit of profits. Patients' health, patients' lives, patients' freedom-all are fair game in the quest for limitless wealth and unbridled power.

The question of evening news and print advertisement for pharmaceuticals is posed. Is this marketing speaking to doctor's in lieu of doctor's reading unbiased research? Or does this research derive from the very company making the pill? Hoadley reveals pharmaceutical sales reps now supply more education to physicians than they obtained in medical school. In other words, Big Pharma has climbed to the top of the totem pole; medical professionals stubbornly cling to their subordinate position; and the poor patient (pun intended) supports the entire structure. Do I need to tell you that the support is vulnerable and under attack? Whether it can remain viable is, or should be, a question of great concern.

Too Profitable to Cure is available online through Hoadley's site. Scott Strumello had turned me on to Brent Hoadley after he posted an Open Letter to Eli Lilly and one of the comments left was from Mr. Hoadley, himself. Definitely worth checking out! Thank you to Scott for the great find and to Brent Hoadley for putting it into words for us!